Deutsche Bank Maintains Hold After Charles River Releases 2012 Guidance

Deutsche Bank has published a research report on Charles River Laboratories

after the company released initial 2012 guidance this morning. In the report, Deutsche Bank writes, "This morning, CRL provided its initial FY12 guidance. This included total top‐line growth of 2‐4% (0‐2% organic with 1% from Fx and 1% from having a 53rd week) and non‐GAAP EPS of $2.60‐$2.70. This is vs. the Street's current estimate of $2.66 and DB's current estimate of $2.65. From a top‐line perspective, we were modeling 1% organic growth, so this is also in line with our assumptions." Deutsche Bank maintains it Hold rating and $32 price target on Charles River, which closed yesterday at $26.49.